ELLINGTON MANAGEMENT GROUP LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$403,000
+32.6%
26,000
+67.7%
0.07%
+231.8%
Q1 2018$304,000
-65.7%
15,500
-77.3%
0.02%
-26.7%
Q1 2017$886,000
+14.0%
68,400
+6.4%
0.03%
-86.0%
Q3 2016$777,000
+447.2%
64,300
+328.7%
0.21%
+250.8%
Q1 2016$142,000
-35.7%
15,000
-8.9%
0.06%
-1.6%
Q3 2015$221,000
+87.3%
16,472
+35.0%
0.06%
+59.0%
Q4 2014$118,000
-13.9%
12,200
-12.2%
0.04%
-39.1%
Q2 2014$137,000
-63.0%
13,900
-58.5%
0.06%
-8.6%
Q3 2013$370,00033,5000.07%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders